Does INSULIN DEGLUDEC Cause Hyperphosphataemia? 96 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Hyperphosphataemia have been filed in association with INSULIN DEGLUDEC (TRESIBA). This represents 0.8% of all adverse event reports for INSULIN DEGLUDEC.
96
Reports of Hyperphosphataemia with INSULIN DEGLUDEC
0.8%
of all INSULIN DEGLUDEC reports
96
Deaths
90
Hospitalizations
How Dangerous Is Hyperphosphataemia From INSULIN DEGLUDEC?
Of the 96 reports, 96 (100.0%) resulted in death, 90 (93.8%) required hospitalization, and 85 (88.5%) were considered life-threatening.
Is Hyperphosphataemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INSULIN DEGLUDEC. However, 96 reports have been filed with the FAERS database.
What Other Side Effects Does INSULIN DEGLUDEC Cause?
Blood glucose increased (2,644)
Blood glucose decreased (983)
Hypoglycaemia (762)
Nausea (543)
Drug ineffective (449)
Dyspnoea (390)
Vomiting (381)
Stress (368)
Weight increased (364)
Constipation (334)
What Other Drugs Cause Hyperphosphataemia?
ALLOPURINOL (139)
LANSOPRAZOLE (138)
ACETAMINOPHEN (132)
SEVELAMER (129)
ONDANSETRON (127)
CALCITRIOL (125)
IPRATROPIUM (123)
ALBUTEROL (122)
METRONIDAZOLE (120)
HYDROMORPHONE (118)
Which INSULIN DEGLUDEC Alternatives Have Lower Hyperphosphataemia Risk?
INSULIN DEGLUDEC vs INSULIN DEGLUDEC\LIRAGLUTIDE
INSULIN DEGLUDEC vs INSULIN DETEMIR
INSULIN DEGLUDEC vs INSULIN GLARGINE
INSULIN DEGLUDEC vs INSULIN GLARGINE-YFGN
INSULIN DEGLUDEC vs INSULIN GLARGINE\LIXISENATIDE